Abzena
San Diego
About Abzena
Abzena is a biologics research partner. They provide biologic and ADC products from concept to clinic. They develop biologics and bioconjugates, and provides the solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $139.4M
- Funding stage: M&A
- Last round: Private Equity (Mar 2022)
- Ticker: lse:ABZA
- Website: abzena.com
- Phone: +1 858 550 4094
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/abzena-5010 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.